A Study to Compare Two Techniques for Pain Control After Bariatric Surgery

Overview

The purpose of this study is to compare the postoperative pain and other clinical outcomes in patients who, during bariatric surgery, will be injected with a local anesthetic (Ropivacaine) through two different techniques.

Full Title of Study: “Laparoscopic Assisted Transversus Abdominis Plane (TAP) Block Vs Local Anesthetic Infiltrations in Bariatric Surgery: a Prospective Randomized Double-Blind Controlled Trial (TAP BLOCK BARIATRIC TRIAL)”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: July 7, 2021

Interventions

  • Procedure: Transversus Abdominis Plane (TAP) block
    • The laparoscopic-assisted Transversus Abdominis Plane (TAP) block will be done just after the optic trocar placement as follow: as landmarks we use the anterior axillary line, in the middle between the iliac crest and the costal margin. After insertion of the optic trocar the peritoneum is visualized. A 14 Gauge needle is inserted 2 cm cranially respect the taken landmark through the skin until the penetration of the internal and external oblique fascias, identified as sudden lowering of resistance. Laparoscopy allows to confirm that the needle did not pass the peritoneum. A solution of 20 ml of Ropivacaine (0.25%) is then injected, observing the formation of a bulge posterior to the transversus abdominis muscle. The procedure is then repeated identically on the contralateral side.
  • Procedure: Port-Site Infiltration (PSI)
    • The Port-Site Infiltration (PSI) will be performed by infiltrating the subcutis and the skin at the trocar site before the trocar placements with a solution of local anesthetic (Ropivacaine 0.25%), a total of 40 ml will be administered.

Arms, Groups and Cohorts

  • Experimental: Arm A – laparoscopic assisted TAP block
    • Patients will undergo the planned bariatric intervention according to the standard of treatment. A solution of 20 ml of the local anesthetic Ropivacaine (0.25%) is then injected for postoperative pain control according to the allocated procedure (TPA).
  • Active Comparator: Arm B – PSI
    • Patients will undergo the planned bariatric intervention according to the standard of treatment. A solution of 20 ml of the local anesthetic Ropivacaine (0.25%) is then injected for postoperative pain control according to the allocated procedure (PSI).

Clinical Trial Outcome Measures

Primary Measures

  • Postoperative Pain
    • Time Frame: at 24 hours post surgery
    • Postoperative pain on the visual analogue scale (VAS) This visual analogue scale measures the subjective pain: patients indicate a position along a continuous line between two end-points to specify their level of pain. Absence of pain is represented by 0 while 10 corresponds to the maximum of pain.

Secondary Measures

  • postoperative pain
    • Time Frame: at 3, 6, 12, 18 hours from surgery
    • Postoperative pain on the visual analogue scale (VAS) at 3, 6, 12, 18 hours. This visual analogue scale measures the subjective pain: patients indicate a position along a continuous line between two end-points to specify their level of pain. Absence of pain is represented by 0 while 10 corresponds to the maximum of pain.
  • Number of Participants With Ropivacaine-Related Adverse Events
    • Time Frame: from surgery up to six weeks after surgery
  • Number of participants with complications
    • Time Frame: from surgery up to six weeks after surgery
    • Number of participants with complications, defined as any alteration from the normal or uneventful postoperative course,
  • lenght of hospital stay
    • Time Frame: during hospitalization,approximately 4 days
    • number of days the participant is being hospitalized
  • in hospital satisfaction
    • Time Frame: during hospitalization,approximately 4 days
    • In hospital satisfaction (measured on the validated Leiden Perioperative Patient Satisfaction -LPPS – questionnaire for the perioperative patients’ satisfaction. This questionnaire assess patient satisfaction with perioperative care. Patients are asked to score each question on a fivepoint scale (from 1 – corresponding to the worse outcome to 5 – the best outcome)

Participating in This Clinical Trial

Inclusion Criteria

  • patients undergoing elective bariatric surgery – age ≥ 18 years – signed informed consent Exclusion Criteria:

  • Pregnant or lactating women, – known allergy to local anesthetics – Chronic pain syndrome.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fabio Garofalo
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Fabio Garofalo, Principal Investigator – Ente Ospedaliero Cantonale, Bellinzona
  • Overall Official(s)
    • Fabio Garofalo, MD, Principal Investigator, EOC Surgeery Department

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.